ATF2 - A transcription factor that elicits oncogenic or tumor suppressor activities

被引:124
作者
Bhoumik, Anindita [1 ]
Ronai, Zeev [1 ]
机构
[1] Burnham Inst Med Res, Program Inflammat, Signal Transduct Program, La Jolla, CA 92037 USA
关键词
ATF2; melanoma; skin cancer; oncogene; tumor suppressor gene; DNA damage response; JNK; p38; ATM; TIP60;
D O I
10.4161/cc.6388
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
The Activating Transcription Factor (ATF2) gene encodes a transcription factor important for normal cellular development and survival. In addition to its role as a transcription factor, ATF2 functions in the DNA damage response and in control of HAT complex activity. So far genetic changes in ATF2 have not been identified in human tumors. Yet altered expression and subcellular localization of ATF2 are associated with tumor stage and prognosis. Our studies in melanoma tumor models identified oncogenic ATF2 activity correlating with development of this tumor type. Inhibiting ATF2 suffices to impede melanoma development. Yet work in other tumor models, including breast and skin tumors reveals that ATF2, in cooperation with mutated oncogenes or tumor suppressor genes, can also elicit tumor suppressor function. These findings suggest tissue- and tumor-specific function of ATF2. This review summarizes the current understanding of ATF2 regulation and function.
引用
收藏
页码:2341 / 2345
页数:5
相关论文
共 43 条
[1]
Berger AJ, 2003, CANCER RES, V63, P8103
[2]
ATM-dependent phosphorylation of ATF2 is required for the DNA damage response [J].
Bhoumik, A ;
Takahashi, S ;
Breitweiser, W ;
Shiloh, Y ;
Jones, N ;
Ronai, Z .
MOLECULAR CELL, 2005, 18 (05) :577-587
[3]
An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis [J].
Bhoumik, A ;
Huang, TG ;
Ivanov, V ;
Gangi, L ;
Qiao, RF ;
Woo, SLC ;
Chen, SH ;
Ronai, Z .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (05) :643-650
[4]
Inhibition of melanoma growth and metastasis by ATF2-derived peptides [J].
Bhoumik, A ;
Gangi, L ;
Ronai, Z .
CANCER RESEARCH, 2004, 64 (22) :8222-8230
[5]
Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity [J].
Bhoumik, A ;
Jones, N ;
Ronai, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (12) :4222-4227
[6]
Bhoumik A, 2001, CLIN CANCER RES, V7, P331
[7]
BHOUMIK A, 2008, J BIOL CHEM
[8]
Suppressor role of activating transcription factor 2 (ATF2) in skin cancer [J].
Bhoumik, Anindita ;
Fichtman, Boris ;
DeRossi, Charles ;
Breitwieser, Wolfgang ;
Kluger, Harriet M. ;
Davis, Sean ;
Subtil, Antonio ;
Meltzer, Paul ;
Krajewski, Stan ;
Jones, Nic ;
Ronai, Ze'ev .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (05) :1674-1679
[9]
ATF2 on the double - activating transcription factor and DNA damage response protein [J].
Bhoumik, Anindita ;
Lopez-Bergami, Pablo ;
Ronai, Ze'ev .
PIGMENT CELL RESEARCH, 2007, 20 (06) :498-506
[10]
BIANCHI AB, 1993, ONCOGENE, V8, P1127